Acadian Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $929K | Buy |
52,525
+47,596
| +966% | +$842K | ﹤0.01% | 995 |
|
|
2025
Q1 | $87K | Buy |
+4,929
| New | +$87K | ﹤0.01% | 1371 |
|
|
2024
Q4 | – | Sell |
-8,712
| Closed | -$136K | – | 2010 |
|
|
2024
Q3 | $136K | Buy |
+8,712
| New | +$136K | ﹤0.01% | 1494 |
|
|
2024
Q2 | – | Sell |
-3,143
| Closed | -$49K | – | 1864 |
|
|
2024
Q1 | $49K | Sell |
3,143
-39,554
| -93% | -$617K | ﹤0.01% | 1384 |
|
|
2023
Q4 | $634K | Buy |
42,697
+37,319
| +694% | +$554K | ﹤0.01% | 970 |
|
|
2023
Q3 | $85K | Buy |
+5,378
| New | +$85K | ﹤0.01% | 1336 |
|
|
2021
Q1 | – | Sell |
-3,091
| Closed | -$536K | – | 2239 |
|
|
2020
Q4 | $536K | Buy |
3,091
+2,026
| +190% | +$351K | ﹤0.01% | 1216 |
|
|
2020
Q3 | $119K | Sell |
1,065
-1,067
| -50% | -$119K | ﹤0.01% | 1610 |
|
|
2020
Q2 | $126K | Buy |
2,132
+109
| +5% | +$6.44K | ﹤0.01% | 1654 |
|
|
2020
Q1 | $137K | Buy |
2,023
+775
| +62% | +$52.5K | ﹤0.01% | 1283 |
|
|
2019
Q4 | $105K | Buy |
+1,248
| New | +$105K | ﹤0.01% | 1438 |
|